Analysis of data from 212 patients collected from 2 pooled studies showed that high expression of TRAF6, not TRAF4, is associated with poor survival rate in breast cancer patients over a 5-year period (Log Hazard Ratio [HR]:1.01, 95% CI: 1.01, 1.01, P < 0.00001) (Table 4) (Table S8). Here, TRAF4 is linked to breast carcinoma.